Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.86+0.16 (+5.98%)
Close on Nov 17, 2026Market cap $115.47MP/E –Yield –
Molecular Partners operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -CHF 51.26M. The highest annual figure on record is CHF 118.57M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 51.26M | – |
| FY2024 | Dec 31, 2024 | -CHF 59.25M | – |
| FY2023 | Dec 31, 2023 | -CHF 59.01M | -149.8% |
| FY2022 | Dec 31, 2022 | CHF 118.57M | – |
| FY2021 | Dec 31, 2021 | -CHF 90.95M | – |
| FY2020 | Dec 31, 2020 | -CHF 28.98M | – |
| FY2019 | Dec 31, 2019 | -CHF 1.19M | – |
See a number that looks wrong?